Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1995 May;100(2):183–185. doi: 10.1111/j.1365-2249.1995.tb03650.x

The role of cellular immunity in systemic vasculitis.

P W Mathieson, D B Oliveira
PMCID: PMC1534317  PMID: 7743652

Full text

PDF
183

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ballieux B. E., van der Burg S. H., Hagen E. C., van der Woude F. J., Melief C. J., Daha M. R. Cell-mediated autoimmunity in patients with Wegener's granulomatosis (WG) Clin Exp Immunol. 1995 May;100(2):186–193. doi: 10.1111/j.1365-2249.1995.tb03651.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bland J. M., Altman D. G. Multiple significance tests: the Bonferroni method. BMJ. 1995 Jan 21;310(6973):170–170. doi: 10.1136/bmj.310.6973.170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brouwer E., Stegeman C. A., Huitema M. G., Limburg P. C., Kallenberg C. G. T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG). Clin Exp Immunol. 1994 Dec;98(3):448–453. doi: 10.1111/j.1365-2249.1994.tb05511.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brouwer E., Tervaert J. W., Horst G., Huitema M. G., van der Giessen M., Limburg P. C., Kallenberg C. G. Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders. Clin Exp Immunol. 1991 Mar;83(3):379–386. doi: 10.1111/j.1365-2249.1991.tb05647.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. DeRemee R. A. The treatment of Wegener's granulomatosis with trimethoprim/sulfamethoxazole: illusion or vision? Arthritis Rheum. 1988 Aug;31(8):1068–1074. doi: 10.1002/art.1780310821. [DOI] [PubMed] [Google Scholar]
  6. Finkel T. H., Török T. J., Ferguson P. J., Durigon E. L., Zaki S. R., Leung D. Y., Harbeck R. J., Gelfand E. W., Saulsbury F. T., Hollister J. R. Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent? Lancet. 1994 May 21;343(8908):1255–1258. doi: 10.1016/s0140-6736(94)92152-0. [DOI] [PubMed] [Google Scholar]
  7. Hohlfeld R., Toyka K. V., Heininger K., Grosse-Wilde H., Kalies I. Autoimmune human T lymphocytes specific for acetylcholine receptor. Nature. 1984 Jul 19;310(5974):244–246. doi: 10.1038/310244a0. [DOI] [PubMed] [Google Scholar]
  8. Jennette J. C., Falk R. J., Andrassy K., Bacon P. A., Churg J., Gross W. L., Hagen E. C., Hoffman G. S., Hunder G. G., Kallenberg C. G. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994 Feb;37(2):187–192. doi: 10.1002/art.1780370206. [DOI] [PubMed] [Google Scholar]
  9. Jennette J. C., Wilkman A. S., Falk R. J. Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am J Pathol. 1989 Nov;135(5):921–930. [PMC free article] [PubMed] [Google Scholar]
  10. Lake P., Mitchison N. A. Associative control of the immune response to cell surface antigens. Immunol Commun. 1976;5(9):795–805. doi: 10.3109/08820137609047620. [DOI] [PubMed] [Google Scholar]
  11. Lim V. S. Recombinant human erythropoietin in predialysis patients. Am J Kidney Dis. 1991 Oct;18(4 Suppl 1):34–37. [PubMed] [Google Scholar]
  12. Lockwood C. M., Thiru S., Isaacs J. D., Hale G., Waldmann H. Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy. Lancet. 1993 Jun 26;341(8861):1620–1622. doi: 10.1016/0140-6736(93)90759-a. [DOI] [PubMed] [Google Scholar]
  13. Londei M., Bottazzo G. F., Feldmann M. Human T-cell clones from autoimmune thyroid glands: specific recognition of autologous thyroid cells. Science. 1985 Apr 5;228(4695):85–89. doi: 10.1126/science.3871967. [DOI] [PubMed] [Google Scholar]
  14. Mathieson P. W., Cobbold S. P., Hale G., Clark M. R., Oliveira D. B., Lockwood C. M., Waldmann H. Monoclonal-antibody therapy in systemic vasculitis. N Engl J Med. 1990 Jul 26;323(4):250–254. doi: 10.1056/NEJM199007263230407. [DOI] [PubMed] [Google Scholar]
  15. Mathieson P. W., Lockwood C. M., Oliveira D. B. T and B cell responses to neutrophil cytoplasmic antigens in systemic vasculitis. Clin Immunol Immunopathol. 1992 May;63(2):135–141. doi: 10.1016/0090-1229(92)90005-9. [DOI] [PubMed] [Google Scholar]
  16. Mathieson P. W., Qasim F. J., Esnault V. L., Oliveira D. B. Animal models of systemic vasculitis. J Autoimmun. 1993 Apr;6(2):251–264. doi: 10.1006/jaut.1993.1022. [DOI] [PubMed] [Google Scholar]
  17. Pinching A. J., Rees A. J., Pussell B. A., Lockwood C. M., Mitchison R. S., Peters D. K. Relapses in Wegener's granulomatosis: the role of infection. Br Med J. 1980 Sep 27;281(6244):836–838. doi: 10.1136/bmj.281.6244.836. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Roep B. O., Kallan A. A., Hazenbos W. L., Bruining G. J., Bailyes E. M., Arden S. D., Hutton J. C., de Vries R. R. T-cell reactivity to 38 kD insulin-secretory-granule protein in patients with recent-onset type 1 diabetes. Lancet. 1991 Jun 15;337(8755):1439–1441. doi: 10.1016/0140-6736(91)93127-u. [DOI] [PubMed] [Google Scholar]
  19. Savage C. O., Winearls C. G., Evans D. J., Rees A. J., Lockwood C. M. Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med. 1985 Aug;56(220):467–483. [PubMed] [Google Scholar]
  20. Schmitt W. H., Heesen C., Csernok E., Rautmann A., Gross W. L. Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis. Association with disease activity. Arthritis Rheum. 1992 Sep;35(9):1088–1096. doi: 10.1002/art.1780350914. [DOI] [PubMed] [Google Scholar]
  21. Schollmeyer P., Grotz W. Ciclosporin in the treatment of Wegener's granulomatosis (WG) and related diseases. APMIS Suppl. 1990;19:54–55. doi: 10.1111/j.1600-0463.1990.tb05738.x. [DOI] [PubMed] [Google Scholar]
  22. Stegeman C. A., Tervaert J. W., Huitema M. G., Kallenberg C. G. Serum markers of T cell activation in relapses of Wegener's granulomatosis. Clin Exp Immunol. 1993 Mar;91(3):415–420. doi: 10.1111/j.1365-2249.1993.tb05918.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Zhang L., Jayne D. R., Zhao M. H., Lockwood C. M., Oliveira D. B. Distribution of MHC class II alleles in primary systemic vasculitis. Kidney Int. 1995 Jan;47(1):294–298. doi: 10.1038/ki.1995.37. [DOI] [PubMed] [Google Scholar]
  24. van der Woude F. J., Daha M. R., van Es L. A. The current status of neutrophil cytoplasmic antibodies. Clin Exp Immunol. 1989 Nov;78(2):143–148. [PMC free article] [PubMed] [Google Scholar]
  25. van der Woude F. J., Rasmussen N., Lobatto S., Wiik A., Permin H., van Es L. A., van der Giessen M., van der Hem G. K., The T. H. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet. 1985 Feb 23;1(8426):425–429. doi: 10.1016/s0140-6736(85)91147-x. [DOI] [PubMed] [Google Scholar]
  26. van der Woude F. J., van Es L. A., Daha M. R. The role of the c-ANCA antigen in the pathogenesis of Wegener's granulomatosis. A hypothesis based on both humoral and cellular mechanisms. Neth J Med. 1990 Apr;36(3-4):169–171. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES